Mycophenolate mofetil treatment for primary glomerular diseases
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 61 (3) , 1098-1114
- https://doi.org/10.1046/j.1523-1755.2002.00214.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisNew England Journal of Medicine, 2000
- Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidneyKidney International, 2000
- Mycophenolate Mofetil Therapy in Lupus NephritisJournal of the American Society of Nephrology, 1999
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletionNephrology Dialysis Transplantation, 1999
- Mycophenolate mofetil prevents the induction of active Heymann nephritisJournal of the American Society of Nephrology, 1998
- Mycophenolate mofetil attenuates renal injury in the rat remnant kidneyKidney International, 1998
- Mycophenolic acidJournal of the American Society of Nephrology, 1998
- Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamideAmerican Journal of Kidney Diseases, 1998
- Successful mycophenolate mofetil treatment of glomerular diseaseAmerican Journal of Kidney Diseases, 1998